The Top Stem Cell Stock Blogs
Stem-cell stocks have become a popular topic for discussion since the beginning of 2009, and a few bloggers have risen to the occasion to meet public demand for stem cell information. Heck, some are even calling 2009 The Year of the Stem Cell. This post is a tribute to them, and a resource for you.
At the beginning of January 2009, some stem cell companies were barely able to pay the bills after being shunned by the U.S. government for many years, so conducting top-tier stem cell research was not always possible. In the same month, stem cell stock prices soared in anticipation of Barack Obama's executive order that allowed federal funding for embryonic stem cell research. For example, Advanced Cell Technology, Inc. (ACTC) went from trading around 4 cents on January 2nd to 29 cents on January 26th, creating windfall profits for investors and national attention for the entire sector. Since then, most stem cell stocks have retreated, others maintained momentum, and some have gone even higher.
Just like with all investments, different factors contribute to the price of a stock at any given moment. The exchange (Pink Sheets, AMEX, NASDAQ, etc.), patents, debt, share structure, management, and speculation (especially with Pink Sheets) can, and do, influence the price a stock is trading at. As a new technology with an unknown future, investing in stem cell companies can be risky, but extremely rewarding down the road if and when advancements lead to commercialized therapies across the globe. Before investing in anything, always keep in mind The Five Commandments of Trading for the Unenlightened Investor.
Here are the best stem cell blogs and sites that I have found to be most useful when researching information on stem cell companies and stocks:
Stem Cell Stock Informer
Stem Cell Stock Informer is a blog maintained by veteran blogger Lawrence "Jose" Sinclair and offers a daily recap of the stem cell market. These recaps are great for on-the-go investors wanting to know how many stem cell stocks were up and down for the day, how they compare to the overall market, and what may be influencing these trends in a concise, to-the-point update.
For the most part, three sections in a post cover it all: A summary for the day, "Big Winners," and "Biggest Drops." More detailed posts can be found throughout the site covering companies like Geron and other important investor-related topics such as relevant public & private institutions and ongoing policy changes. There are also useful links to various resources and even a long list of stem cell stock tickers.
